Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

Systematic interrogation of gene function requires the ability to perturb gene expression in a robust and generalizable manner. Here we describe structure-guided engineering of a CRISPR-Cas9 complex to mediate efficient transcriptional activation at endogenous genomic loci. We used these engineered...

Full description

Bibliographic Details
Main Authors: Konermann, Silvana, Brigham, Mark D., Trevino, Alexandro E., Joung, Julia, Barcena, Clea, Hsu, Patrick D., Habib, Naomi, Gootenberg, Jonathan S., Nishimasu, Hiroshi, Nureki, Osamu, Zhang, Feng, Abudayyeh, Omar Osama
Other Authors: Harvard University--MIT Division of Health Sciences and Technology
Format: Article
Language:en_US
Published: 2016
Online Access:http://hdl.handle.net/1721.1/102589
https://orcid.org/0000-0003-2782-2509
https://orcid.org/0000-0001-7915-1685
https://orcid.org/0000-0001-6656-5002
https://orcid.org/0000-0002-7979-3220
_version_ 1826211392439451648
author Konermann, Silvana
Brigham, Mark D.
Trevino, Alexandro E.
Joung, Julia
Barcena, Clea
Hsu, Patrick D.
Habib, Naomi
Gootenberg, Jonathan S.
Nishimasu, Hiroshi
Nureki, Osamu
Zhang, Feng
Abudayyeh, Omar Osama
author2 Harvard University--MIT Division of Health Sciences and Technology
author_facet Harvard University--MIT Division of Health Sciences and Technology
Konermann, Silvana
Brigham, Mark D.
Trevino, Alexandro E.
Joung, Julia
Barcena, Clea
Hsu, Patrick D.
Habib, Naomi
Gootenberg, Jonathan S.
Nishimasu, Hiroshi
Nureki, Osamu
Zhang, Feng
Abudayyeh, Omar Osama
author_sort Konermann, Silvana
collection MIT
description Systematic interrogation of gene function requires the ability to perturb gene expression in a robust and generalizable manner. Here we describe structure-guided engineering of a CRISPR-Cas9 complex to mediate efficient transcriptional activation at endogenous genomic loci. We used these engineered Cas9 activation complexes to investigate single-guide RNA (sgRNA) targeting rules for effective transcriptional activation, to demonstrate multiplexed activation of ten genes simultaneously, and to upregulate long intergenic non-coding RNA (lincRNA) transcripts. We also synthesized a library consisting of 70,290 guides targeting all human RefSeq coding isoforms to screen for genes that, upon activation, confer resistance to a BRAF inhibitor. The top hits included genes previously shown to be able to confer resistance, and novel candidates were validated using individual sgRNA and complementary DNA overexpression. A gene expression signature based on the top screening hits correlated with markers of BRAF inhibitor resistance in cell lines and patient-derived samples. These results collectively demonstrate the potential of Cas9-based activators as a powerful genetic perturbation technology.
first_indexed 2024-09-23T15:05:11Z
format Article
id mit-1721.1/102589
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T15:05:11Z
publishDate 2016
record_format dspace
spelling mit-1721.1/1025892022-09-29T12:36:25Z Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex Konermann, Silvana Brigham, Mark D. Trevino, Alexandro E. Joung, Julia Barcena, Clea Hsu, Patrick D. Habib, Naomi Gootenberg, Jonathan S. Nishimasu, Hiroshi Nureki, Osamu Zhang, Feng Abudayyeh, Omar Osama Harvard University--MIT Division of Health Sciences and Technology Massachusetts Institute of Technology. Department of Biological Engineering Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences McGovern Institute for Brain Research at MIT Konermann, Silvana Brigham, Mark D. Trevino, Alexandro E. Abudayyeh, Omar Osama Barcena, Clea Hsu, Patrick D. Gootenberg, Jonathan S. Zhang, Feng Joung, Julia Systematic interrogation of gene function requires the ability to perturb gene expression in a robust and generalizable manner. Here we describe structure-guided engineering of a CRISPR-Cas9 complex to mediate efficient transcriptional activation at endogenous genomic loci. We used these engineered Cas9 activation complexes to investigate single-guide RNA (sgRNA) targeting rules for effective transcriptional activation, to demonstrate multiplexed activation of ten genes simultaneously, and to upregulate long intergenic non-coding RNA (lincRNA) transcripts. We also synthesized a library consisting of 70,290 guides targeting all human RefSeq coding isoforms to screen for genes that, upon activation, confer resistance to a BRAF inhibitor. The top hits included genes previously shown to be able to confer resistance, and novel candidates were validated using individual sgRNA and complementary DNA overexpression. A gene expression signature based on the top screening hits correlated with markers of BRAF inhibitor resistance in cell lines and patient-derived samples. These results collectively demonstrate the potential of Cas9-based activators as a powerful genetic perturbation technology. National Science Foundation (U.S.) (Graduate Research Fellowship) United States. Dept. of Energy (Computational Science Graduate Fellowship) National Institute of Mental Health (U.S.) (DP1-MH100706) National Institute of Neurological Disorders and Stroke (U.S.) (R01-NS07312401) National Science Foundation (U.S.) W. M. Keck Foundation Kinship Foundation. Searle Scholars Program Klingenstein Foundation Vallee Foundation Simons Foundation 2016-05-23T00:51:14Z 2016-05-23T00:51:14Z 2016-05-22 Article http://purl.org/eprint/type/JournalArticle 0028-0836 1476-4687 http://hdl.handle.net/1721.1/102589 Konermann, Silvana, Mark D. Brigham, Alexandro E. Trevino, Julia Joung, Omar O. Abudayyeh, Clea Barcena, Patrick D. Hsu, et al. “Genome-Scale Transcriptional Activation by an Engineered CRISPR-Cas9 Complex.” Nature 517, no. 7536 (December 10, 2014): 583–88. https://orcid.org/0000-0003-2782-2509 https://orcid.org/0000-0001-7915-1685 https://orcid.org/0000-0001-6656-5002 https://orcid.org/0000-0002-7979-3220 en_US http://dx.doi.org/10.1038/nature14136 Nature Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. application/pdf PMC
spellingShingle Konermann, Silvana
Brigham, Mark D.
Trevino, Alexandro E.
Joung, Julia
Barcena, Clea
Hsu, Patrick D.
Habib, Naomi
Gootenberg, Jonathan S.
Nishimasu, Hiroshi
Nureki, Osamu
Zhang, Feng
Abudayyeh, Omar Osama
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
title Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
title_full Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
title_fullStr Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
title_full_unstemmed Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
title_short Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
title_sort genome scale transcriptional activation by an engineered crispr cas9 complex
url http://hdl.handle.net/1721.1/102589
https://orcid.org/0000-0003-2782-2509
https://orcid.org/0000-0001-7915-1685
https://orcid.org/0000-0001-6656-5002
https://orcid.org/0000-0002-7979-3220
work_keys_str_mv AT konermannsilvana genomescaletranscriptionalactivationbyanengineeredcrisprcas9complex
AT brighammarkd genomescaletranscriptionalactivationbyanengineeredcrisprcas9complex
AT trevinoalexandroe genomescaletranscriptionalactivationbyanengineeredcrisprcas9complex
AT joungjulia genomescaletranscriptionalactivationbyanengineeredcrisprcas9complex
AT barcenaclea genomescaletranscriptionalactivationbyanengineeredcrisprcas9complex
AT hsupatrickd genomescaletranscriptionalactivationbyanengineeredcrisprcas9complex
AT habibnaomi genomescaletranscriptionalactivationbyanengineeredcrisprcas9complex
AT gootenbergjonathans genomescaletranscriptionalactivationbyanengineeredcrisprcas9complex
AT nishimasuhiroshi genomescaletranscriptionalactivationbyanengineeredcrisprcas9complex
AT nurekiosamu genomescaletranscriptionalactivationbyanengineeredcrisprcas9complex
AT zhangfeng genomescaletranscriptionalactivationbyanengineeredcrisprcas9complex
AT abudayyehomarosama genomescaletranscriptionalactivationbyanengineeredcrisprcas9complex